Analysts Set Omega Healthcare Investors, Inc. (NYSE:OHI) Price Target at $40.18

Omega Healthcare Investors, Inc. (NYSE:OHI - Get Free Report) has earned an average recommendation of "Moderate Buy" from the twelve brokerages that are covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $40.18.

Several research analysts have recently commented on OHI shares. Mizuho lifted their price target on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the company a "neutral" rating in a report on Thursday, December 5th. Truist Financial upped their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "hold" rating in a report on Wednesday, September 4th. BNP Paribas upgraded Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price objective for the company in a research report on Thursday, October 31st. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Finally, Royal Bank of Canada boosted their price target on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a "sector perform" rating in a report on Monday, November 11th.

Hedge Funds Weigh In On Omega Healthcare Investors

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its holdings in shares of Omega Healthcare Investors by 353.4% in the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust's stock valued at $27,000 after buying an additional 516 shares during the period. Dunhill Financial LLC acquired a new stake in Omega Healthcare Investors in the 3rd quarter valued at about $31,000. True Wealth Design LLC bought a new position in shares of Omega Healthcare Investors during the 3rd quarter valued at about $31,000. DiNuzzo Private Wealth Inc. acquired a new position in shares of Omega Healthcare Investors in the 3rd quarter worth approximately $33,000. Finally, V Square Quantitative Management LLC raised its holdings in shares of Omega Healthcare Investors by 49.5% in the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust's stock worth $40,000 after purchasing an additional 323 shares in the last quarter. 65.25% of the stock is owned by institutional investors.

Omega Healthcare Investors Stock Performance

Omega Healthcare Investors stock traded down $0.43 during mid-day trading on Friday, reaching $37.72. The company's stock had a trading volume of 1,224,854 shares, compared to its average volume of 1,709,374. The firm has a market cap of $10.18 billion, a price-to-earnings ratio of 27.74, a PEG ratio of 1.22 and a beta of 0.98. Omega Healthcare Investors has a twelve month low of $27.53 and a twelve month high of $44.42. The business has a 50 day moving average price of $39.98 and a 200-day moving average price of $38.39. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10.

Omega Healthcare Investors Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were issued a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 annualized dividend and a yield of 7.10%. Omega Healthcare Investors's payout ratio is 197.06%.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.